Ausgabe 3/2013
Inhalt (17 Artikel)
review
Personalized medicine for breast cancer: dream or reality?
Lina Pugliano, Dimitrios Zardavas, Martine Piccart
short review
Aggressive lymphoma at ASH 2012: new standards and new perspectives
Thomas Nösslinger, Thomas Nösslinger
short review
ASH 2012 update chronic lymphocytic leukemia—the best is yet to come
Lukas Weiss, Thomas Melchardt, Richard Greil, Georg Hopfinger
short review
Philadelphia-negative myeloproliferative neoplasms at the 2012 ASH meeting: a personal summary
Stefan Schmidt
short review
Acute myeloid leukemia: highlights from the 54th ASH meeting held in Atlanta, Georgia
Elisabeth Koller
short review
Georgia on my mind: multiple myeloma highlights at ASH 2012
Wolfgang Willenbacher, Ella Willenbacher
short review
What’s new in Hodgkin’s lymphoma: ASH 2012 and more
Thomas Melchardt, Lukas Weiss, Richard Greil, Alexander Egle
short review
Cancer-associated venous thromboembolism: risk assessment, prevention, and treatment
Clemens Feistritzer
short review
Biosimilars versus generics: scientific basics and clinical implications
Harald H. Sitte, Michael Freissmuth
short review
Controversial issues in the therapy of oesophageal carcinoma
Thomas Ruhstaller, Michael Stahl
short review
Radiofrequency ablation in gastrointestinal cancer: obstacles and goals
Gerlig Widmann, Reto Bale